2.1 Million Cardiac Rhythm Patients in Indonesia Spikes the Beat of the CRM Market, Finds Frost & Sullivan

Informations

• Publié par: frost-sullivan
• Nombre de lectures: 3
• Langue: English

Extrait

2.1 Million Cardiac Rhythm Patients in

Indonesia Spikes the Beat of the CRM Market,

Finds Frost & Sullivan

PR Newswire

JAKARTA, Indonesia, June 20, 2012

- Pacemakers Emerge the Most Popular Device with 49.6 Per cent of the Sales,

Closely Followed by Cardiac Ablation with 42.2 Per cent

JAKARTA, Indonesia

,

June 20, 2012

/PRNewswire/ --

Indonesia

has a high

prevalence of both communicable and non-communicable diseases; among

non-communicable diseases, cardiovascular disease's incidence is 7.2 per cent

of the total population of 247 million and it is also the fourth leading cause of

mortality. Of these, 2.1 million suffer from disorders caused by the rhythm of

heart, signifying vast opportunities for the cardiac rhythm management (CRM)

market on a small base.

New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com),

Indonesian Market for Cardiac Rhythm Management

, finds that the

market earned revenues of

$1.75 million

in 2011 and estimates this to reach

$4.15 million

in 2016 at a compound annual growth rate of 18.9 per cent.

The occurrence of cardiovascular diseases is on the rise due to sedentary

lifestyles, unhealthy eating habits and urbanization. However, changes in

healthcare services legislation, revamp in health insurance policies, an aging

population, affluent and dormant life style, smoking and the urge to be treated

will boost the Indonesian CRM market.

In 2011, single-chamber pacemakers were the most popular device for CRM

due to their low cost, familiarity and simplicity of implantation.

"Both hospitals and healthcare professionals have indicated a preference for

pacemakers, making it the largest segment, with a sale of 417 units,

accounting for 49.6 per cent of the Indonesian CRM market," says Frost &

Sullivan's Consultant, Poornima Srinivasan.

Pacemakers will gain further traction with its use in cardiac resynchronization

therapy due to the product's success rates, efficacy and longevity.

Currently, there are limited interventional cardiology and electrophysiology

centres to perform cardiac rhythm implants.

"To meet the needs of the growing incidence, the Indonesian government is

encouraging private hospitals and foreign participants to establish hospitals in

the country," notes Srinivasan.

"As the rising wealth and population growth necessitate quality healthcare

services in

Indonesia

, the government has decided to extend the maximum

limit for foreign ownership from 47 percent to 67 percent. As a result of this

legislation, more foreign hospitals with sophisticated technologies and

infrastructure are expected to invest in

Indonesia

," says Eugene van de Weerd,

Country Director, Frost & Sullivan –

Indonesia

. "Such a move is expected to

result in more cardiac, oncological, and other surgeries taking place within the

country, thereby curtailing the need for medical treatment abroad." Eugene

concluded.

About Frost & Sullivan